Clinical Trial

Prevalence and Risk Factors of Hyperkalemia in Non-Dialysis Chronic Kidney Disease Patients in Community

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 11, 2025 (before its estimated July 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational study is to investigate the prevalence and risk factors of hyperkalemia in community-based non-dialysis chronic kidney disease (CKD) patients. The main questions it aims to answer are: 1. What is the prevalence of hyperkalemia in non-dialysis CKD patients in a primary care setting? 2. What are the key risk factors influencing the occurrence of hyperkalemia in this population? Researchers will collect clinical and demographic data from participants across 18 community health centers and use both point-of-care testing (POCT) and laboratory-based methods to measure serum potassium levels and related parameters. Participants will: 1. Provide blood samples for POCT and laboratory testing. 2. Participate in interviews or questionnaires to gather clinical and lifestyle information. The findings will be used to construct a risk prediction model for hyperkalemia, aiming to optimize screening pathways and improve disease management strategies in primary care.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-18.
Status change: Not Yet Recruiting → Recruiting 2025-07-08
Trial Details
NCT Number NCT06940414
Lead Sponsor Xiujuan Zang
Conditions Hyperkalemia, Chronic Kidney Disease(CKD)
Enrollment 1,890 participants
Start Date 2025-04-28
Primary Completion 2025-07-31 (estimated)
Study Completion 2025-09-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-11